254 related articles for article (PubMed ID: 18782690)
1. Bone mineral density following long-term use of antiepileptic drugs in a tropical Asian country.
Phabphal K; Limapichat K; Sathirapanya P; Setthawatcharawanich S; Leelawattana R; Thammakumpee N; Thamaprasit A; Geater A
Epileptic Disord; 2008 Sep; 10(3):213-8. PubMed ID: 18782690
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
Chou IJ; Lin KL; Wang HS; Wang CJ
Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of osteoporosis in Thai men.
Pongchaiyakul C; Apinyanurag C; Soontrapa S; Soontrapa S; Pongchaiyakul C; Nguyen TV; Rajatanavin R
J Med Assoc Thai; 2006 Feb; 89(2):160-9. PubMed ID: 16579001
[TBL] [Abstract][Full Text] [Related]
4. Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients.
Lien G; Flatø B; Haugen M; Vinje O; Sørskaar D; Dale K; Johnston V; Egeland T; Førre Ø
Arthritis Rheum; 2003 Aug; 48(8):2214-23. PubMed ID: 12905475
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptic drugs and high prevalence of low bone mineral density in a group of inpatients with chronic epilepsy.
Beerhorst K; Tan IY; De Krom M; Verschuure P; Aldenkamp AP
Acta Neurol Scand; 2013 Oct; 128(4):273-80. PubMed ID: 23461582
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy.
Triantafyllou N; Lambrinoudaki I; Armeni E; Evangelopoulos EM; Boufidou F; Antoniou A; Tsivgoulis G
J Neurol Sci; 2010 Mar; 290(1-2):131-4. PubMed ID: 20056251
[TBL] [Abstract][Full Text] [Related]
7. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study.
Malik P; Gasser RW; Kemmler G; Moncayo R; Finkenstedt G; Kurz M; Fleischhacker WW
Alcohol Clin Exp Res; 2009 Feb; 33(2):375-81. PubMed ID: 19053976
[TBL] [Abstract][Full Text] [Related]
8. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
Pastores GM; Elstein D; Hrebícek M; Zimran A
Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
Legroux-Gerot I; Vignau J; Collier F; Cortet B
Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy.
Ryan CW; Huo D; Stallings JW; Davis RL; Beer TM; McWhorter LT
Urology; 2007 Jul; 70(1):122-6. PubMed ID: 17656221
[TBL] [Abstract][Full Text] [Related]
12. Progressive bone deficit in epilepsy.
Sheth RD; Binkley N; Hermann BP
Neurology; 2008 Jan; 70(3):170-6. PubMed ID: 18057319
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density of the spine and femur in a group of healthy Moroccan men.
El Maghraoui A; Ghazi M; Gassim S; Mounach A; Ghozlani I; Nouijai A; Achemlal L; Bezza A; Dehhaoui M
Bone; 2009 May; 44(5):965-9. PubMed ID: 19168162
[TBL] [Abstract][Full Text] [Related]
14. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
Paker N; Bugdayci D; Tekdos D; Dere C; Kaya B
J Stroke Cerebrovasc Dis; 2009; 18(2):139-43. PubMed ID: 19251190
[TBL] [Abstract][Full Text] [Related]
15. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of osteopenia and osteoporosis in adults with Type 1 diabetes.
Hamilton EJ; Rakic V; Davis WA; Chubb SA; Kamber N; Prince RL; Davis TM
Diabet Med; 2009 Jan; 26(1):45-52. PubMed ID: 19125760
[TBL] [Abstract][Full Text] [Related]
17. The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin.
Phabphal K; Geater A; Limapichart K; Sathirapanya P; Setthawatcharawanich S; Witeerungrot N; Thammakumpee N; Leelawattana R
Epilepsia; 2013 Feb; 54(2):249-55. PubMed ID: 23281616
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug.
Phabphal K; Geater A; Leelawattana R; Sathirapunya P; Sattawatcharawanich S; Limapichat K
Bone; 2009 Aug; 45(2):232-7. PubMed ID: 19394456
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparins and antiplatelet drugs, and bone mineral density in dialysis patients.
Grzegorzewska AE; Młot-Michalska M
Adv Perit Dial; 2008; 24():125-31. PubMed ID: 18986016
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care.
Jekovec-Vrhovsek M; Kocijancic A; Prezelj J
Dev Med Child Neurol; 2000 Jun; 42(6):403-5. PubMed ID: 10875526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
